TREA

90099351 - INEIGHTBIO

Follow

Information

  • Trademark
  • 90099351
  • Serial Number
    90099351
  • Filing Date
    August 07, 2020
    4 years ago
  • Transaction Date
    December 13, 2021
    2 years ago
  • Status Date
    December 13, 2021
    2 years ago
  • Location Date
    December 13, 2021
    2 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    LEVINE, HOWARD B
  • Attorney Docket Number
    37070-00070
    Attorney Name
    Mark Jansen
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
INEIGHTBIO
Case File Statements
  • GS0051: Pharmaceutical preparations, namely, oncological preparations; Reagent, diagnostics and therapeutic preparations for medical use in oncology; Targeted medical preparations for use in oncology; Pharmaceutical preparations for use in the treatment of cancer and tumors; Pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; Pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; Pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; Medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; Pharmaceutical and biological preparations comprised of modified T cells used for multiple modes of treatment against tumor resistance and immunosuppression
  • GS0421: Research, development, and evaluation of new products; Pharmaceutical, medicine, and vaccine research and development services; Technical research in the field of pharmaceutical studies; Laboratory analysis and research into new drugs and pharmaceutical products; Development of scientific measuring and testing methods in the field of oncology; Design, development, research, and conducting clinical trials for others in connection with drugs, pharmaceuticals, and cellular therapies for the treatment and/or prevention of cancer; Research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; Providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; Scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology
  • GS0441: Development of diagnostic medical measuring and testing methods in the field of cancer therapy and treatment
Case File Event Statements
  • 12/13/2021 - 2 years ago
    16 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 12/13/2021 - 2 years ago
    15 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 5/24/2021 - 3 years ago
    14 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 5/24/2021 - 3 years ago
    13 - FINAL REFUSAL E-MAILED Type: GNFR
  • 5/24/2021 - 3 years ago
    12 - FINAL REFUSAL WRITTEN Type: CNFR
  • 4/29/2021 - 3 years ago
    11 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 4/28/2021 - 3 years ago
    10 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 4/21/2021 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/20/2021 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/20/2021 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/20/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/20/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/20/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/20/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/8/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 8/11/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP